title: Coinfection of HPV-11 and HPV-16 in a case of laryngeal squamous papillomas with severe dysplasia.
abstract: Human papillomavirus (HPV) types 6 and 11 have been associated with benign laryngeal papilloma, while HPV-16 is occasionally associated with laryngeal carcinoma. In this study, a case of laryngeal squamous papillomas with severe dysplasia was evaluated for the presence of HPV infection. The biopsy specimens were taken from a 58-year-old female patient at two different time points 3 months apart. Architecturally, the tumor showed papillary configuration reminiscent of squamous papilloma. Cytologically, the lesion showed morphologic features characteristic of severe squamous epithelial dysplasia. HPV infection was determined by DNA in situ hybridization using type-specific HPV-DNA probes. HPV-11 probes demonstrated homogeneous nuclear staining, suggesting productive viral replication. In contrast, HPV-16 probe produced a speckled pattern, suggesting HPV-16 DNA integration. Normal laryngeal epithelium did not yield specific hybridization. The presence of HPV-11 and HPV-16 was confirmed by PCR using HPV type-specific primers. Immunocytochemical staining was performed to detect Ki-67, a proliferation marker, and p53. Ki-67 expression was demonstrated throughout the whole thickness of epithelium. Staining for p53 was negative. This study suggests that multiple HPV infections can occur in the same lesion and that HPV-16 infection and its DNA integration may contribute to the occurrence of severe dysplasia in the lesion described.
authors.affiliation: Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.
authors.forename: K Y
authors.initials: KY
authors.lastname: Lin
authors.forename: W H
authors.initials: WH
authors.lastname: Westra
authors.forename: H K
authors.initials: HK
authors.lastname: Kashima
authors.forename: P
authors.initials: P
authors.lastname: Mounts
authors.forename: T C
authors.initials: TC
authors.lastname: Wu
mesh_terms: D002467:Cell Nucleus / Q000648:ultrastructure / Q000821:virology; D004396:Coloring Agents; D015344:DNA Probes, HPV; D004279:DNA, Viral / Q000235:genetics; D004848:Epithelium / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D015967:Gene Expression Regulation, Viral; D006801:Humans; D017403:In Situ Hybridization; D019394:Ki-67 Antigen / Q000032:analysis / Q000235:genetics; D007822:Laryngeal Neoplasms / Q000473:pathology / Q000821:virology*; D007830:Larynx / Q000378:metabolism; D008875:Middle Aged; D010212:Papilloma / Q000473:pathology / Q000821:virology*; D027383:Papillomaviridae / Q000145:classification*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000473:pathology; D016133:Polymerase Chain Reaction; D014170:Transformation, Genetic; D016159:Tumor Suppressor Protein p53 / Q000032:analysis / Q000235:genetics; D014412:Tumor Virus Infections / Q000175:diagnosis* / Q000473:pathology; D015854:Up-Regulation; D014779:Virus Replication
chemical_list: D004396:Coloring Agents; D015344:DNA Probes, HPV; D004279:DNA, Viral; D019394:Ki-67 Antigen; D016159:Tumor Suppressor Protein p53